Please login to the form below
heart attack
This page shows the latest heart attack news and features for those working in and with pharma, biotech and healthcare.
Novo Nordisk set to acquire Emisphere Technology for $1.8bn
such as heart attack, stroke or death in adults with type 2 diabetes with known heart disease.
Latest news
-
AstraZeneca’s Farxiga scores another FDA fast-track designation
or cardiovascular death in adult following an acute myocardial infarction or heart attack. ... secondary prevention of cardiovascular events among high-risk patients who have experienced a heart attack.
-
AstraZeneca’s Brilinta reduces rate of secondary stroke
heart attack and/or death when given to patients who had previously suffered a stroke or transient transient ischaemic attack. ... The drug is already approved for the treatment of acute coronary syndrome (ACS) and for the secondary prevention of
-
Amarin shares tumble following Vascepa patent loss
treating indicated patients at high risk of cardiovascular events, such as heart attack and stroke,” said Thero.
-
Novartis plans inclisiran trial in the UK
Novartis also plans to conduct ORION-4, the ongoing study for patients who have already had a heart attack or stroke, with this study making the UK the global trial centre.
-
AZ says Brilinta hits the mark in new stroke trial
When used on its own by patients who had already suffered a stroke or transient ischaemic attack (TIA), it demonstrated a trend towards fewer subsequent events of stroke, heart attack ... The drug is already approved for the treatment of acute coronary
More from news
Approximately 5 fully matching, plus 224 partially matching documents found.
Latest Intelligence
-
The evolution of marketing – the Amgen way
Yet, cardiovascular disease is still the leading cause of death in Europe, and 80% of premature cases of heart disease and stroke are preventable. ... predict which cardiovascular disease patients are at high risk of a second event, such as a heart attack
-
Changing direction: adapting to a rapidly-evolving environment
In the era of the algorithm, your doctor can now predict you’ll have a fatal heart attack five years before it hits you. ... If we’re going to exploit the brilliance of technology to change behaviours and transform health outcomes, marketing and
-
Insights from Cannes Lions Health Festival 2018
sea. He describes the impact – the pain, the chaos and the suffering – and we experience the attack with him through Jaws-style shots. ... The film ends with a big reveal: this wasn’t a shark attack, but a heart attack.
-
Proving real-world value
Insights reach R&D that ordinarily take years; beta-blockers, for example, found expanded use to control hypertension only after retrospective analysis of four decades of use in heart attack patients.”.
-
Why health psychology is the answer to tackling adherence
Therapy (OAP), a treatment that has been shown to reduce the risk of death or non-fatal heart attack.
More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
World Heart Day 2020: It's time to make our clinical trials more inclusive
One study found the average time for a South Asian patient to receive treatment for a heart attack was nearly double compared with a white person. ... For example, one study found that centrally located pain is symbolic of a heart attack in 87% white
-
Covid-19: what could it mean for the diabetic population?
a heart attack and twice as likely to have a stroke than people who do not have the condition. This, combined with the vast number of people affected by the disease,
-
Understanding the "Big Picture"
In this case, of the male patients with ACS, 27% experienced angina and 73% experienced a heart attack. ... This quickly demonstrates that the majority of male patients who experience a heart attack will be found within the non ST-elevated heart attack
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director - Med Comms Agency
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- GSK launches late-stage testing of RSV vaccine candidate in older adults
- Pfizer/BioNTech to develop a booster dose for their COVID-19 vaccine
- Sinovac’s COVID-19 vaccine appears safe in older adults
- bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
- FDA schedules meeting on 26 February to review J&J’s one-dose COVID-19 vaccine
- FDA authorises flexible storage for Pfizer/BioNTech COVID-19 vaccine
- UK introduces Rare Diseases Framework to improve the lives of people with rare diseases
- Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease
- UPDATED: Regeneron’s COVID-19 antibody cocktail shows ‘clear efficacy’
- Merck to acquire Pandion Therapeutics for $1.85bn
- bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video
PMHub
Research Partnership
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...
Latest intelligence
- 4 ways to recruit Alzheimer’s disease patients for your clinical trial
- What key things do you need to remember to reach patients living with Alzheimer’s disease?...
- Integrating competitive intelligence into business development, licensing and M&A strategy
- The advantages of partnering with a competitive intelligence or knowledge management team...
- Reaching patients and HCPs during the pandemic
- COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
Quick links
Infographics
